You are here: Welcome » Shelley Deeks

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision
Previous revision
Both sides next revision
shelley_deeks [2022/04/19 03:23]
liam [National Advisory Committee on Immunization]
shelley_deeks [2023/04/19 21:33] (current)
liam
Line 30: Line 30:
 ==== University of Toronto ==== ==== University of Toronto ====
  
-Deeks is an Associate Professor at the [[univeristy_of_toronto:Dalla Lana School of Public Health]] at the [[University of Toronto]].((//Deeks, Shelley L.// Dalla Lana School of Public Health. Retrieved March 19, 2022, from https://www.dlsph.utoronto.ca/faculty-profile/deeks-shelley-l/))+Deeks is an Associate Professor at the [[Dalla Lana School of Public Health]] at the [[University of Toronto]].((//Deeks, Shelley L.// Dalla Lana School of Public Health. Retrieved March 19, 2022, from https://www.dlsph.utoronto.ca/faculty-profile/deeks-shelley-l/))
  
 ==== Canadian Immunization Research Network ==== ==== Canadian Immunization Research Network ====
Line 38: Line 38:
 ==== Public Health Ontario (2009-2021) ==== ==== Public Health Ontario (2009-2021) ====
  
-In 2009, Deeks joined [[public_health_agencies:Canada:Public Health Ontario]]. She served as Chief of Communicable Diseases, Emergency Preparedness and Response and was at some point appointed Chief Health Protection Officer. Deeks was the "overall executive lead" on Ontario's [[COVID-19 pandemic]] response.((//Briefing with Public Health Ontario.// (2020, September 28). Long-Term Care COVID-19 Commission. https://web.archive.org/web/20210810150355/http://www.ltccommission-commissionsld.ca/transcripts/pdf/GovOntario_PHO_Briefing_with_Public_Health.pdf)) She announced her departure in December 2020, citing the Ontario government's failure to follow [[public health]] guidance.((McPhee, J. (2020, December 10). //Public health chief who made waves in Ontario moving to Nova Scotia.// SaltWire. https://archive.ph/cpCBY)) ((//Dr. Shelley Deeks.// Public Health Ontario. Retrieved March 20, 2022, from https://archive.ph/i16k5)) +In 2009, Deeks joined [[Public Health Ontario]]. She served as Chief of Communicable Diseases, Emergency Preparedness and Response and was at some point appointed Chief Health Protection Officer. Deeks was the "overall executive lead" on Ontario's [[COVID-19 pandemic]] response.((//Briefing with Public Health Ontario.// (2020, September 28). Long-Term Care COVID-19 Commission. https://web.archive.org/web/20210810150355/http://www.ltccommission-commissionsld.ca/transcripts/pdf/GovOntario_PHO_Briefing_with_Public_Health.pdf)) She announced her departure in December 2020, citing the Ontario government's failure to follow [[public health]] guidance.((McPhee, J. (2020, December 10). //Public health chief who made waves in Ontario moving to Nova Scotia.// SaltWire. https://archive.ph/cpCBY)) ((//Dr. Shelley Deeks.// Public Health Ontario. Retrieved March 20, 2022, from https://archive.ph/i16k5)) 
 ==== World Health Organization (2017-present) ==== ==== World Health Organization (2017-present) ====
  
-Deeks has acted as a [[World Health Organization]] SAGE Polio Working Group Member since October 2017. She has received compensation for travel expenses in the range of $1,000-$5,000.+Deeks has acted as a [[World Health Organization]] SAGE Polio Working Group Member since October 2017.((//SAGE working group on polio.// (2023, February 3). World Health Organization. http://archive.today/2023.04.19-193056/https://www.who.int/groups/strategic-advisory-group-of-experts-on-immunization/working-groups/polio-vaccine)) She has received compensation for travel expenses in the range of $1,000-$5,000.
 ==== GAVI, the vaccine alliance (2018-2020) ==== ==== GAVI, the vaccine alliance (2018-2020) ====
  
-From October 2018 to October 2020, Deeks served as a member of the Vaccine Innovation Prioritisation Strategy (VIPS) Steering Committee for [[GAVI|GAVI, the vaccine alliance]]. She has received compensation for travel expenses in the range of $1,000-$5,000.+From October 2018 to October 2020, Deeks served as a member of the [[Vaccine Innovation Prioritisation Strategy]] (VIPS) Steering Committee for [[GAVI|GAVI, the vaccine alliance]]. She has received compensation for travel expenses in the range of $1,000-$5,000.
 ==== Province of Nova Scotia (2021-present) ==== ==== Province of Nova Scotia (2021-present) ====
  
Line 58: Line 58:
 Deeks is the Chair of the [[National Advisory Committee on Immunization]] (NACI).((Public Health Agency of Canada. (2022, February 25). //National Advisory Committee on Immunization (NACI): Membership and representation.// Government of Canada. https://web.archive.org/web/20220318105951/https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/naci-membership-representation.html#fn1-rf)) She previously served as Chair of the National Advisory Committee on Immunization (NACI) Herpes Zoster Working Group, and Vice-chair of NACI before her ultimate promotion to Chair. Deeks is the Chair of the [[National Advisory Committee on Immunization]] (NACI).((Public Health Agency of Canada. (2022, February 25). //National Advisory Committee on Immunization (NACI): Membership and representation.// Government of Canada. https://web.archive.org/web/20220318105951/https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/naci-membership-representation.html#fn1-rf)) She previously served as Chair of the National Advisory Committee on Immunization (NACI) Herpes Zoster Working Group, and Vice-chair of NACI before her ultimate promotion to Chair.
  
-She is a member of the [[Advisory Committee on Immunization Practices]], serving as a liaison representative on behalf of NACI.((//ACIP Member Roster.// (2021). U.S. Centres for Disease Control and Prevention. https://web.archive.org/web/20220419012215/https://www.cdc.gov/vaccines/acip/members/members-508.pdf))+She is a member of the [[Advisory Committee on Immunization Practices]], serving as a liaison representative on behalf of NACI.((//ACIP Member Roster.// (2021). U.S. Centres for Disease Control and Prevention. https://web.archive.org/web/20220419012215/https://www.cdc.gov/vaccines/acip/members/members-508.pdf)) ((//ACIP Current Membership Roster.// (2022, January 12). U.S. Centers for Disease Control and Prevention. https://www.cdc.gov/vaccines/acip/members/index.html))
 ===== Research ===== ===== Research =====
  
Line 85: Line 85:
 ==== Canadian Immunization Conference (2018) ==== ==== Canadian Immunization Conference (2018) ====
  
-Deeks delivered a number of presentations at the [[Canadian Immunization Conference]] in 2018. The event was organized by the [[Canadian Association for Immunization Research, Evaluation and Education]] (CAIRE), the [[Canadian Public Health Association]] (CPHA), the [[Canadian Paediatric Society]], and the [[Public Health Agency of Canada]] (PHAC), and sponsored by [[pharmaceutical_companies:411 Vaccines]], [[pharmaceutical_companies:GlaxoSmithKline]], [[pharmaceutical_companies:Innovative Medicines Canada]], [[pharmaceutical_companies:Medicago]], [[pharmaceutical_companies:Merck]], [[pharmaceutical_companies:Pfizer]], [[public_health_agencies:canada:Public Health Ontario]], [[pharmaceutical_companies:Sanofi]], [[pharmaceutical_companies:Seqirus]] and [[pharmaceutical_companies:Valneva]].((//CIC 2018 Final Program.// (2018, November). Canadian Immunization Conference. https://web.archive.org/web/20220320193739/https://cic-cci.ca/wp-content/uploads/2018/11/CIC-2018-Final-Program.pdf))+Deeks delivered a number of presentations at the [[Canadian Immunization Conference]] in 2018. The event was organized by the [[Canadian Association for Immunization Research, Evaluation and Education]] (CAIRE), the [[Canadian Public Health Association]] (CPHA), the [[Canadian Paediatric Society]], and the [[Public Health Agency of Canada]] (PHAC), and sponsored by [[Vaccines411]], [[pharmaceutical_companies:GlaxoSmithKline]], [[Innovative Medicines Canada]], [[pharmaceutical_companies:Medicago]], [[pharmaceutical_companies:Merck]], [[pharmaceutical_companies:Pfizer]], [[Public Health Ontario]], [[pharmaceutical_companies:Sanofi]], [[pharmaceutical_companies:Seqirus]] and [[pharmaceutical_companies:Valneva]].((//CIC 2018 Final Program.// (2018, November). Canadian Immunization Conference. https://web.archive.org/web/20220320193739/https://cic-cci.ca/wp-content/uploads/2018/11/CIC-2018-Final-Program.pdf))
  
 ==== Ontario Public Health Convention (2018) ==== ==== Ontario Public Health Convention (2018) ====
  
 Deeks presented at the 2018 [[Ontario Public Health Convention]] on the topics of the epidemiology of [[varicella]], waning [[measles]] immunity in infants, and [[mumps]] activity in Ontario. Deeks presented at the 2018 [[Ontario Public Health Convention]] on the topics of the epidemiology of [[varicella]], waning [[measles]] immunity in infants, and [[mumps]] activity in Ontario.
Back to top